Neurogene NGNE
NASDAQ NGNE
$25.28 -0.72 (-2.77%)
At close: Nov 10, 2026 · 4:00 PM EST

Neurogene (NGNE) Tax Provisions (2013 - 2014)

Updated

Neurogene (NGNE) reported Tax Provisions of -$222.00 for FY2014, compared with -$5,000 in FY2013.

Analysis

Neurogene (NGNE) Tax Provisions (2013 - 2014) Analysis & Trends

  • According to Business Quant data, Tax Provisions came in at -$5,000 in FY2013 and $42,294 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -176.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 609.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 291.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 634.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 134.00 Mn
10 Neurogene 577.56 Mn -425.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -222.00
Dec 31, 2013 44.00
Sep 30, 2013 -5,044.00
API Access

Neurogene Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=NGNE&period=max&api_key=YOUR_API_KEY